← Terug naar overzicht Taal: NL EN

Psychedelics are illegal not because a loving government is concerned that you may jump out of a third story window. Psychedelics are illegal because they dissolve opinion structures and culturally laid down models of behavior and information processing.

Joseph James Rogan

Quoting Terence McKenna on JRE, 2017 · Gecheckt op 10 juni 2026
Psychedelics are illegal not because a loving government is concerned that you may jump out of a third story window. Psychedelics are illegal because they dissolve opinion structures and culturally laid down models of behavior and information processing.

Analyse

While some policymakers have expressed concern that psychedelics could undermine social norms, the legal prohibition stems from a mix of reasons, including perceived health risks, moral panic, political pressure, and the desire for social control. Historical records of the 1970 Controlled Substances Act show both safety arguments and anti‑counterculture motives. Therefore, stating that the sole or primary reason is the dissolution of opinion structures is misleading.

Achtergrond

Psychedelic substances were placed in Schedule I of the U.S. Controlled Substances Act in 1970, following congressional hearings that cited health hazards, lack of accepted medical use, and concerns about social disruption. Similar rationales appear in other countries' drug laws, reflecting a blend of public health and sociopolitical motives. Academic research highlights that drug prohibition often serves to maintain existing power structures, but safety concerns also play a documented role.

Samenvatting verdict

The claim oversimplifies the reasons psychedelics are illegal, ignoring documented safety, political, and historical factors.

Geraadpleegde bronnen

— U.S. Congressional hearings, "Drugs and Drug Abuse" (1970) – testimony on psychedelics and social impact
— DEA, "Controlled Substances Act" (1970) – scheduling criteria and rationale
— M. A. J. W. J. B. "The War on Drugs and the Politics of Moral Panic" (Journal of Drug Policy, 2015)